Joint Corp. (JYNT)

NASDAQ:
JYNT
| Latest update: Feb 7, 2026, 7:14 PM

Stock events for The Joint Corp. (United States) (JYNT)

Over the past six months, The Joint Corp.'s stock price has declined by 14.89%. Key events include the release of Q3 2025 financial results on November 6, 2025. On December 11, 2025, the company signed an agreement to sell 22 corporate-owned clinics in the Southeast for $1.5 million and terminated an agreement for 45 clinics in Southern California, aligning with a strategic shift to a pure-play franchisor model. On January 5, 2026, Ron Stilwell was appointed as SVP Operations and Patient Experience. In November 2025, the Board authorized an additional $12 million for its stock repurchase program. On July 30, 2025, the company announced plans to restate its financial statements for 2024 and Q1 2025 due to errors in calculating impairment charges, leading to a 4.00% stock decline.

Demand Seasonality affecting The Joint Corp. (United States)’s stock price

The Joint Chiropractic offers "Back Friday Deals" during the holiday season, suggesting increased demand or promotional activity during this period. The company's model of no-appointments and convenient locations aims to make care accessible year-round, but specific promotions around holidays suggest an effort to capitalize on seasonal needs.

Overview of The Joint Corp. (United States)’s business

The Joint Corp. is the largest operator, manager, and franchisor of chiropractic clinics in the United States, known as The Joint Chiropractic®. It is headquartered in Scottsdale, Arizona, and offers an affordable, accessible chiropractic care model without insurance or appointments. The company's primary product is chiropractic adjustments, delivered through personalized treatment plans focused on pain relief and ongoing preventative care, with various membership and wellness packages available.

JYNT’s Geographic footprint

The Joint Corp. has a significant presence across the United States, with over 950 locations nationwide operating in 43 states.

JYNT Corporate Image Assessment

The Joint Chiropractic has received positive recognition within the franchising and healthcare industries, including being named "No. 1 in Chiropractic Services" by Entrepreneur and recognition from SUCCESS. However, a 2021 report raised concerns about potential issues such as overbilling and forged transactions, and the company's July 2025 announcement of a financial restatement due to errors in calculating impairment charges and the identification of a material weakness in internal control over financial reporting could also be seen as an event impacting its reputation for financial accuracy and internal controls.

Ownership

The Joint Corp. (JYNT) is heavily controlled by institutional investors, who hold a 77.57% stake as of November 2025, while individual ownership is 14.41%. Major institutional owners include Bandera Partners LLC, Vanguard Group Inc. / Vanguard Fiduciary Trust Co., BlackRock, Inc., Skylands Capital, LLC, JCP Investment Management, LLC, Geode Capital Management, Llc, and State Street Corp. / State Street Global Advisors, Inc. Jeff Gramm, portfolio manager for Bandera Partners LLC, is a director on the Board.

Price Chart

$9.72

1.36%
(1 month)

Top Shareholders

Bandera Partners LLC
26.28%
The Vanguard Group, Inc.
6.73%
BlackRock, Inc.
6.30%
Skylands Capital LLC
5.99%
JCP Investment Management LLC
3.96%
Topline Capital Management LLC
2.87%
First Foundation, Inc.
2.28%
Geode Holdings Trust
2.28%

Trade Ideas for JYNT

Today

Sentiment for JYNT

News
Social

Buzz Talk for JYNT

Today

Social Media

FAQ

What is the current stock price of The Joint Corp. (United States)?

As of the latest update, The Joint Corp. (United States)'s stock is trading at $9.72 per share.

What’s happening with The Joint Corp. (United States) stock today?

Today, The Joint Corp. (United States) stock is up by 1.36%, possibly due to news.

What is the market sentiment around The Joint Corp. (United States) stock?

Current sentiment around The Joint Corp. (United States) stock is negative, based on recent news, trading volume, and analyst opinions.

Is The Joint Corp. (United States)'s stock price growing?

Over the past month, The Joint Corp. (United States)'s stock price has increased by 1.36%.

How can I buy The Joint Corp. (United States) stock?

You can buy The Joint Corp. (United States) stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol JYNT

Who are the major shareholders of The Joint Corp. (United States) stock?

Major shareholders of The Joint Corp. (United States) include institutions such as Bandera Partners LLC (26.28%), The Vanguard Group, Inc. (6.73%), BlackRock, Inc. (6.30%) ... , according to the latest filings.